| Molecular Triaging of Newly Diagnosed Breast Cancer (NCT01159236) | M.D. Anderson Cancer Center | 2010-09-01 |
| Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer (NCT01187199) | M.D. Anderson Cancer Center | 2010-08-19 |
| Social Contextual Influences on Physical Activity (NCT01195337) | M.D. Anderson Cancer Center | 2010-08-16 |
| Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma (NCT01176604) | M.D. Anderson Cancer Center | 2010-08-04 |
| Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML) (NCT01160354) | M.D. Anderson Cancer Center | 2010-08-01 |
| Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL) (NCT01191749) | M.D. Anderson Cancer Center | 2010-08-01 |
| Symptom Burden in Patients With Cancer- and Treatment-Related Skin Problems (NCT01193036) | M.D. Anderson Cancer Center | 2010-08-01 |
| Multimedia Patient Education (NCT01184534) | M.D. Anderson Cancer Center | 2010-08-01 |
| 4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies (NCT01139151) | M.D. Anderson Cancer Center | 2010-08-01 |
| Temsirolimus In Phase 0 (NCT01417065) | M.D. Anderson Cancer Center | 2010-08-01 |
| Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma (NCT01185366) | M.D. Anderson Cancer Center | 2010-08-01 |
| Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) (NCT01183663) | M.D. Anderson Cancer Center | 2010-08-01 |
| SCH-900105 in Recurrent Glioblastoma (NCT01189513) | M.D. Anderson Cancer Center | 2010-08-01 |
| Azacitidine and CAPOX in Metastatic Colorectal Cancer (NCT01193517) | M.D. Anderson Cancer Center | 2010-08-01 |
| Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol (NCT01196130) | M.D. Anderson Cancer Center | 2010-08-01 |
| Symptom Inventory for Gastrointestinal Stromal Tumors (NCT01178307) | M.D. Anderson Cancer Center | 2010-07-29 |
| Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study. (NCT01173692) | M.D. Anderson Cancer Center | 2010-07-22 |
| Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant (NCT01174082) | M.D. Anderson Cancer Center | 2010-07-20 |
| Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies (NCT01165658) | M.D. Anderson Cancer Center | 2010-07-16 |
| Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT01154920) | M.D. Anderson Cancer Center | 2010-07-09 |
| Trientine and Carboplatin in Advanced Malignancies (NCT01178112) | M.D. Anderson Cancer Center | 2010-07-01 |
| Survivorship in Lynch Syndrome Families (NCT01126840) | M.D. Anderson Cancer Center | 2010-06-20 |
| Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies (NCT01094860) | M.D. Anderson Cancer Center | 2010-06-08 |
| CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) (NCT01134575) | M.D. Anderson Cancer Center | 2010-06-04 |
| Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients (NCT01157533) | M.D. Anderson Cancer Center | 2010-06-01 |
| Bendamustine and Bevacizumab for Advanced Cancers (NCT01152203) | M.D. Anderson Cancer Center | 2010-06-01 |
| FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib (NCT01143779) | M.D. Anderson Cancer Center | 2010-06-01 |
| Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT) (NCT01134146) | M.D. Anderson Cancer Center | 2010-05-27 |
| Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist (NCT00960752) | M.D. Anderson Cancer Center | 2010-05-20 |
| Combining Varenicline and Bupropion for Smoking Cessation (NCT00943618) | M.D. Anderson Cancer Center | 2010-05-17 |
| Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) (NCT01122615) | M.D. Anderson Cancer Center | 2010-05-01 |
| Ipilimumab + Temozolomide in Metastatic Melanoma (NCT01119508) | M.D. Anderson Cancer Center | 2010-05-01 |
| Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer (NCT01068249) | M.D. Anderson Cancer Center | 2010-04-30 |
| Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies (NCT01113476) | M.D. Anderson Cancer Center | 2010-04-27 |
| Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL) (NCT01096992) | M.D. Anderson Cancer Center | 2010-04-19 |
| Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer (NCT01048853) | M.D. Anderson Cancer Center | 2010-04-15 |
| First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT01097746) | M.D. Anderson Cancer Center | 2010-04-14 |
| TKI258 in Castrate Resistant Prostate Cancer (NCT00831792) | M.D. Anderson Cancer Center | 2010-04-07 |
| Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy (NCT02357992) | M.D. Anderson Cancer Center | 2010-04-05 |
| Simultaneous Integrated Boost (SIB) in Esophageal Cancer (NCT01102088) | M.D. Anderson Cancer Center | 2010-04-01 |
| Pleural Catheters Versus Thoracoscopic Pleurodesis (NCT01117740) | M.D. Anderson Cancer Center | 2010-04-01 |
| Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients (NCT00966277) | M.D. Anderson Cancer Center | 2010-04-01 |
| TPI 287 in Patients With Recurrent Glioblastoma Multiforme (NCT01113463) | M.D. Anderson Cancer Center | 2010-04-01 |
| Caphosol in Sarcoma Patients With Mucositis (NCT00965172) | M.D. Anderson Cancer Center | 2010-04-01 |
| Smoking Cessation Treatment for Head & Neck Cancer Patients (NCT01098955) | M.D. Anderson Cancer Center | 2010-03-24 |
| TTP607 in Refractory Solid Malignancies (NCT00939172) | M.D. Anderson Cancer Center | 2010-03-01 |
| Lapatinib With Sirolimus or Metformin (NCT01087983) | M.D. Anderson Cancer Center | 2010-03-01 |
| Fluorescent Dyes for Lymph Node Mapping (NCT01095913) | M.D. Anderson Cancer Center | 2010-03-01 |
| Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer (NCT01087554) | M.D. Anderson Cancer Center | 2010-03-01 |
| Lenalidomide and High-Dose Melphalan (NCT01079936) | M.D. Anderson Cancer Center | 2010-03-01 |
| Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients (NCT01003626) | M.D. Anderson Cancer Center | 2010-03-01 |
| Eltrombopag for Post Transplant Thrombocytopenia (NCT01000051) | M.D. Anderson Cancer Center | 2010-02-17 |
| Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (NCT01064479) | M.D. Anderson Cancer Center | 2010-02-05 |
| A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma (NCT01067066) | M.D. Anderson Cancer Center | 2010-02-03 |
| Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides (NCT01073267) | M.D. Anderson Cancer Center | 2010-02-01 |
| Phase II Study of Tesetaxel in Metastatic Melanoma (NCT01064713) | M.D. Anderson Cancer Center | 2010-02-01 |
| Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01002755) | M.D. Anderson Cancer Center | 2010-01-19 |
| Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma (NCT00904722) | M.D. Anderson Cancer Center | 2010-01-01 |
| Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS) (NCT00903760) | M.D. Anderson Cancer Center | 2010-01-01 |
| Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction (NCT01025154) | M.D. Anderson Cancer Center | 2010-01-01 |
| Physician Perceptions About Parenteral Hydration in Latin America and Spain (NCT01011140) | M.D. Anderson Cancer Center | 2010-01-01 |
| Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) (NCT01067469) | M.D. Anderson Cancer Center | 2010-01-01 |
| Docetaxel and Sirolimus in Patients With Advanced Malignancies (NCT01054313) | M.D. Anderson Cancer Center | 2010-01-01 |
| HAI Abraxane With Gemcitabine and Bevacizumab (NCT01057264) | M.D. Anderson Cancer Center | 2010-01-01 |
| M. D. Anderson Symptom Inventory - Ovarian Cancer (NCT01037751) | M.D. Anderson Cancer Center | 2009-12-30 |
| Chlorhexidine Gel Therapy for Cariogenic Oral Microflora (NCT01036412) | M.D. Anderson Cancer Center | 2009-12-01 |
| Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System (NCT01030497) | M.D. Anderson Cancer Center | 2009-12-01 |
| Comparison of PEM Uptake Value (PUV) and Standardized Uptake Value (SUV) in Patients With Malignancies of the Breast (NCT01031238) | M.D. Anderson Cancer Center | 2009-12-01 |
| 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) (NCT01038635) | M.D. Anderson Cancer Center | 2009-12-01 |
| Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System (NCT01008930) | M.D. Anderson Cancer Center | 2009-12-01 |
| Study of Weekly LOC-paclitaxel Injection for Melanoma (NCT01039844) | M.D. Anderson Cancer Center | 2009-12-01 |
| Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide (NCT01010217) | M.D. Anderson Cancer Center | 2009-11-05 |
| Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma (NCT00967044) | M.D. Anderson Cancer Center | 2009-11-01 |
| Ondansetron Versus Aprepitant Plus Ondansetron for Emesis (NCT00954941) | M.D. Anderson Cancer Center | 2009-11-01 |
| Chemotherapy-Induced Peripheral Neuropathy Survey (NCT01016028) | M.D. Anderson Cancer Center | 2009-11-01 |
| Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies (NCT01015222) | M.D. Anderson Cancer Center | 2009-11-01 |
| RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia (NCT00968253) | M.D. Anderson Cancer Center | 2009-11-01 |
| Symptom Burden in Chronic Myeloid Leukemia (CML) (NCT01046305) | M.D. Anderson Cancer Center | 2009-11-01 |
| Patient-Reported Outcomes-Based Palliative and Hospice Care Practice: A Usability Study (NCT01024166) | M.D. Anderson Cancer Center | 2009-11-01 |
| Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer (NCT00903006) | M.D. Anderson Cancer Center | 2009-11-01 |
| Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) (NCT01019317) | M.D. Anderson Cancer Center | 2009-11-01 |
| Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver (NCT00766220) | M.D. Anderson Cancer Center | 2009-10-01 |
| Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation (NCT00990249) | M.D. Anderson Cancer Center | 2009-10-01 |
| Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) (NCT00948064) | M.D. Anderson Cancer Center | 2009-09-08 |
| HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver (NCT00980239) | M.D. Anderson Cancer Center | 2009-09-01 |
| Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma (NCT00970996) | M.D. Anderson Cancer Center | 2009-09-01 |
| Infusion of Expanded Cord Blood T Cells (NCT00972101) | M.D. Anderson Cancer Center | 2009-09-01 |
| Determinants of Smoking Cessation Among Latinos (NCT01008748) | M.D. Anderson Cancer Center | 2009-09-01 |
| Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients (NCT00965341) | M.D. Anderson Cancer Center | 2009-09-01 |
| Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia (NCT00936117) | M.D. Anderson Cancer Center | 2009-09-01 |
| Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma (NCT00966693) | M.D. Anderson Cancer Center | 2009-08-25 |
| Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment. (NCT00967369) | M.D. Anderson Cancer Center | 2009-08-24 |
| Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain Metastases (NCT00950001) | M.D. Anderson Cancer Center | 2009-08-13 |
| Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers (NCT00948129) | M.D. Anderson Cancer Center | 2009-08-10 |
| Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer (NCT00954226) | M.D. Anderson Cancer Center | 2009-08-05 |
| Discount Generic Prescription Study (NCT00971022) | M.D. Anderson Cancer Center | 2009-08-01 |
| Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) (NCT00939159) | M.D. Anderson Cancer Center | 2009-08-01 |
| Lenalidomide and Paclitaxel in Prostate Cancer (NCT00933426) | M.D. Anderson Cancer Center | 2009-08-01 |
| High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer (NCT00934128) | M.D. Anderson Cancer Center | 2009-08-01 |
| Study of Bortezomib in Combination With Cyclophosphamide and Rituximab (NCT00958256) | M.D. Anderson Cancer Center | 2009-08-01 |